U.S. flag

An official website of the United States government

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Links from MedGen

Items: 1 to 20 of 439

1.
Phage display library selection of a hypoxia-binding scFv antibody for liver cancer metabolic marker discovery
Jing Liu, Qing Zhang, Hang Chen, Zhihui Gao, Yao Li, Zhongyuan Sun, Rong Xiang, Sihe Zhang
Oncotarget. 2016 Jun 21; 7(25): 38105–38121. Published online 2016 May 18. doi: 10.18632/oncotarget.9460
PMCID:
PMC5122375
AbstractArticlePDF–11M
2.
Adeno-Associated Virus 2-Mediated Hepatocellular Carcinoma is Very Rare in Korean Patients
Kyoung-Jin Park, Jongan Lee, June-Hee Park, Jae-Won Joh, Choon Hyuck David Kwon, Jong-Won Kim
Ann Lab Med. 2016 Sep; 36(5): 469–474. Published online 2016 Jun 24. doi: 10.3343/alm.2016.36.5.469
PMCID:
PMC4940491
AbstractArticlePDF–185K
3.
Characteristics of an outpatient chronic hepatitis B virus infection cohort
Danyenne Rejane de Assis, Simone de Barros Tenore, João Renato Rebello Pinho, David Salomão Lewi, Paulo Roberto Abrão Ferreira
Einstein (Sao Paulo) 2015 Apr-Jun; 13(2): 189–195. doi: 10.1590/S1679-45082015AO3269
PMCID:
PMC4943808
AbstractArticlePDF–557K
4.
The effect of LOXL2 in hepatocellular carcinoma
Linghong Wu, Yuan Zhang, Ying Zhu, Qingwei Cong, Yan Xiang, Linlin Fu
Mol Med Rep. 2016 Sep; 14(3): 1923–1932. Published online 2016 Jul 6. doi: 10.3892/mmr.2016.5474
PMCID:
PMC4991726
AbstractArticlePDF–1.6M
5.
GALNT14 Genotype Predicts Postoperative Outcome of Stage III Colorectal Cancer With Oxaliplatin as Adjuvant Chemotherapy
Wey-Ran Lin, Jy-Ming Chiang, Kung-Hao Liang, Siew-Na Lim, Ming-Wei Lai, Yung-Kuan Tsou, Tzu-Yun Hsieh, Chih-Kai Hsu, Chau-Ting Yeh
Medicine (Baltimore) 2016 Apr; 95(17): e3487. Published online 2016 Apr 29. doi: 10.1097/MD.0000000000003487
PMCID:
PMC4998711
AbstractArticlePDF–332K
6.
Long non-coding RNA TUSC7 acts a molecular sponge for miR-10a and suppresses EMT in hepatocellular carcinoma
Yufeng Wang, Zhikui Liu, Bowen Yao, Changwei Dou, Meng Xu, Yumo Xue, Linglong Ding, Yuli Jia, Hongyong Zhang, Qing Li, Kangsheng Tu, Yang Jiao, Qingguang Liu, Cheng Guo
Tumour Biol. 2016 Aug; 37(8): 11429–11441. Published online 2016 Mar 22. doi: 10.1007/s13277-016-4892-6
PMCID:
PMC4999477
AbstractArticlePDF–3.5M
7.
Peroxisome Proliferator-Activated Receptor γ Expression Is Inversely Associated with Macroscopic Vascular Invasion in Human Hepatocellular Carcinoma
Hui-Tzu Hsu, Ming-Ta Sung, Chih-Chun Lee, Yin-Ju Kuo, Chin-Wen Chi, Hsin-Chen Lee, Cheng-Yuan Hsia
Int J Mol Sci. 2016 Aug; 17(8): 1226. Published online 2016 Jul 29. doi: 10.3390/ijms17081226
PMCID:
PMC5000624
AbstractArticlePDF–4.5M
8.
Treatment Response and Long-Term Outcome of Peginterferon α and Ribavirin Therapy in Korean Patients with Chronic Hepatitis C
Chang Ho Jung, Soon Ho Um, Tae Hyung Kim, Sun Young Yim, Sang Jun Suh, Hyung Joon Yim, Yeon Seok Seo, Hyuk Soon Choi, Hoon Jai Chun
Gut Liver. 2016 Sep; 10(5): 808–817. Published online 2016 Apr 28. doi: 10.5009/gnl15360
PMCID:
PMC5003206
AbstractArticlePDF–195K
9.
Genetic polymorphisms of immune checkpoint proteins PD-1 and TIM-3 are associated with survival of patients with hepatitis B virus-related hepatocellular carcinoma
Zhu Li, Na Li, Fang Li, Zhihua Zhou, Jiao Sang, Zhao Jin, Huihui Liu, Qunying Han, Yi Lv, Zhengwen Liu
Oncotarget. 2016 May 3; 7(18): 26168–26180. Published online 2016 Mar 28. doi: 10.18632/oncotarget.8435
PMCID:
PMC5041972
AbstractArticlePDF–4.2M
10.
Telomerase reverse transcriptase promoter mutations in hepatitis B virus-associated hepatocellular carcinoma
Xunjun Yang, Xiuchan Guo, Yao Chen, Guorong Chen, Yin Ma, Kate Huang, Yuning Zhang, Qiongya Zhao, Cheryl A. Winkler, Ping An, Jianxin Lyu
Oncotarget. 2016 May 10; 7(19): 27838–27847. Published online 2016 Apr 1. doi: 10.18632/oncotarget.8539
PMCID:
PMC5053691
AbstractArticlePDF–1.8M
11.
eNOS polymorphisms and clinical outcome in advanced HCC patients receiving sorafenib: final results of the ePHAS study
Andrea Casadei Gardini, Giorgia Marisi, Luca Faloppi, Emanuela Scarpi, Francesco Giuseppe Foschi, Massimo Iavarone, Gianfranco Lauletta, Jody Corbelli, Martina Valgiusti, Floriana Facchetti, Cristina della Corte, Luca Maria Neri, Stefano Tamberi, Stefano Cascinu, Mario Scartozzi, Dino Amadori, Oriana Nanni, Elena Tenti, Paola Ulivi, Giovanni Luca Frassineti
Oncotarget. 2016 May 10; 7(19): 27988–27999. Published online 2016 Apr 4. doi: 10.18632/oncotarget.8569
PMCID:
PMC5053704
AbstractArticlePDF–1.9M
12.
Downregulation of miRNA-638 promotes angiogenesis and growth of hepatocellular carcinoma by targeting VEGF
Jiwen Cheng, Yanke Chen, Pu Zhao, Xi Liu, Jian Dong, Jianhui Li, Chen Huang, Rongqian Wu, Yi Lv
Oncotarget. 2016 May 24; 7(21): 30702–30711. Published online 2016 Apr 22. doi: 10.18632/oncotarget.8930
PMCID:
PMC5058711
AbstractArticlePDF–5.0M
13.
Loss of AIM2 expression promotes hepatocarcinoma progression through activation of mTOR-S6K1 pathway
Xiaomin Ma, Pengbo Guo, Yumin Qiu, Kun Mu, Lihui Zhu, Wei Zhao, Tao Li, Lihui Han
Oncotarget. 2016 Jun 14; 7(24): 36185–36197. Published online 2016 May 4. doi: 10.18632/oncotarget.9154
PMCID:
PMC5094992
AbstractArticlePDF–9.3M
14.
Methylation-mediated repression of microRNA-129-2 suppresses cell aggressiveness by inhibiting high mobility group box 1 in human hepatocellular carcinoma
Zhikui Liu, Changwei Dou, Bowen Yao, Meng Xu, Linglong Ding, Yufeng Wang, Yuli Jia, Qing Li, Hongyong Zhang, Kangsheng Tu, Tao Song, Qingguang Liu
Oncotarget. 2016 Jun 14; 7(24): 36909–36923. Published online 2016 May 15. doi: 10.18632/oncotarget.9377
PMCID:
PMC5095048
AbstractArticlePDF–14M
15.
Increasing Prevalence of Cirrhosis among US Adults Aware or Unaware of their Chronic Hepatitis C Virus Infection
Prowpanga Udompap, Ajitha Mannalithara, Naeyun Heo, Donghee Kim, W. Ray Kim
J Hepatol. Author manuscript; available in PMC 2016 Jun 29.
Published in final edited form as: J Hepatol. 2016 May; 64(5): 1027–1032. Published online 2016 Jan 22. doi: 10.1016/j.jhep.2016.01.009
PMCID:
PMC4926998
AbstractArticlePDF–1.0M
16.
Monoacylglycerol lipase promotes progression of hepatocellular carcinoma via NF-κB-mediated epithelial-mesenchymal transition
Weiping Zhu, Yiming Zhao, Jiamin Zhou, Xin Wang, Qi Pan, Ning Zhang, Longrong Wang, Miao Wang, Dihua Zhan, Zeyang Liu, Xigan He, Dening Ma, Shuang Liu, Lu Wang
J Hematol Oncol. 2016; 9: 127. Published online 2016 Nov 25. doi: 10.1186/s13045-016-0361-3
PMCID:
PMC5123220
AbstractArticlePDF–2.8M
17.
Molecular and proteomic insight into Notch1 characterization in hepatocellular carcinoma
Catia Giovannini, Manuela Minguzzi, Filippo Genovese, Michele Baglioni, Alessandra Gualandi, Matteo Ravaioli, Maddalena Milazzo, Simona Tavolari, Luigi Bolondi, Laura Gramantieri
Oncotarget. 2016 Jun 28; 7(26): 39609–39626. Published online 2016 May 6. doi: 10.18632/oncotarget.9203
PMCID:
PMC5129957
AbstractArticlePDF–4.5M
18.
NUPR1, a new target in liver cancer: implication in controlling cell growth, migration, invasion and sorafenib resistance
M R Emma, J L Iovanna, D Bachvarov, R Puleio, G R Loria, G Augello, S Candido, M Libra, A Gulino, V Cancila, J A McCubrey, G Montalto, M Cervello
Cell Death Dis. 2016 Jun; 7(6): e2269. Published online 2016 Jun 23. doi: 10.1038/cddis.2016.175
PMCID:
PMC5143401
AbstractArticlePDF–4.7M
19.
Immune checkpoint proteins PD-1 and TIM-3 are both highly expressed in liver tissues and correlate with their gene polymorphisms in patients with HBV-related hepatocellular carcinoma
Zhu Li, Na Li, Fang Li, Zhihua Zhou, Jiao Sang, Yanping Chen, Qunying Han, Yi Lv, Zhengwen Liu
Medicine (Baltimore) 2016 Dec; 95(52): e5749. Published online 2016 Dec 30. doi: 10.1097/MD.0000000000005749
PMCID:
PMC5207584
AbstractArticlePDF–483K
20.
Increased FGF19 copy number is frequently detected in hepatocellular carcinoma with a complete response after sorafenib treatment
Masaki Kaibori, Kazuko Sakai, Morihiko Ishizaki, Hideyuki Matsushima, Marco A. De Velasco, Kosuke Matsui, Hiroya Iida, Hiroaki Kitade, A-Hon Kwon, Hiroaki Nagano, Hiroshi Wada, Seiji Haji, Tadashi Tsukamoto, Akishige Kanazawa, Yutaka Takeda, Shigekazu Takemura, Shoji Kubo, Kazuto Nishio
Oncotarget. 2016 Aug 2; 7(31): 49091–49098. Published online 2016 Jun 15. doi: 10.18632/oncotarget.10077
PMCID:
PMC5226492
AbstractArticlePDF–2.3M

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Filter your results:

Find related data

Recent activity

Clear Turn Off Turn On

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...
You are here: NCBI > Literature > PubMed Central (PMC)
Support Center